← Back
Data updated: Mar 29, 2026
ACTELION
CardiovascularRespiratoryNeurology
Big Pharma
ACTELION is a major pharmaceutical company focused on Cardiovascular, Respiratory, Neurology. Key products include OPSUMIT.
2001
Since
7
Drugs
-
Trials
14
Approved (2yr)
Key Drugs
Top Drug Revenues Pro
Loading...
Revenue Over Time Pro
Loading...
Therapeutic Areas
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
Cardiovascular 49%
5 drugs Phase 3: 15 Phase 2: 6 Phase 1: 8
Respiratory 45%
5 drugs Phase 3: 13 Phase 2: 5 Phase 1: 8
Neurology 5%
0 drugs Phase 3: 3
Infectious Disease 1%
0 drugs Phase 2: 1
Pipeline Forecast
Loading...
Loading...
Upcoming Trial Milestones Pro
Loading...
Patent Cliff Pro
Loading...
Loading...
Loading...
Competitors by Therapeutic Area
GE HEALTHCARE specialty
Infectious Disease, Neurology, Cardiovascular, Respiratory
LEDERLE big-pharma
Infectious Disease, Cardiovascular, Neurology, Respiratory
GSK big-pharma
Infectious Disease, Respiratory, Neurology
APOTHECON specialty
Infectious Disease, Cardiovascular, Respiratory
Novo Nordisk big-pharma
Cardiovascular, Infectious Disease, Neurology